FDA on Friday approved the first gene therapy to treat a rare type of muscular atrophy in infants, and Novartis, which manufactures the drug, has said it will set the treatment's list price at $2.125 million—making it the highest-priced drug in the world.
The measure, signed into law last week, is scheduled to take effect Aug. 28, in today's bite-sized hospital and health industry news from Hawaii, Missouri, and Washington, D.C.
A new CDC report found the percentage of U.S. adults ages 45 to 60 dying of cancer is continuing to fall, even as the percentage of U.S. adults dying of heart disease is rising—but that doesn't mean we should overlook the trends among all age groups, says Advisory Board's Deirdre Saulet.
Fortune recently released its 65th annual list of the 500 companies that generated the most revenue in the previous fiscal year, featuring 41 health care systems and companies. But that doesn’t include high-profile "disruptors" such as Amazon and Google, which Advisory Board's Aaron Mauck says providers should regard with a "healthy dose of paranoia."
In July, Orlando Health will open a new 110-bed, four-story rehabilitation center that flipped the traditional health care facility design model on its head, creating what its senior project designer says is "a hotel that offers exceptional medical care," Naseem Miller reports for the Orlando Sentinel.
Parents across the country are downplaying their child-care obligations to appear 100% committed to their office jobs—a practice of "secret parenting" that harms parents and employers alike, Emily Oster, an economist at Brown University, writes for The Atlantic.
In recent years, Baylor Scott & White and Ascension have rolled out their own standardized strategies to treat sepsis, and their programs are helping reduce mortality, Harris Meyer reports for Modern Healthcare.
Print All Daily Briefing Article from
05/29/2019
Share:
Have a Question?
x
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.
